BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34368097)

  • 21. Long-term outcome for Down syndrome patients with hematopoietic disorders.
    Li MJ; Lee NC; Yang YL; Yen HJ; Chang HH; Chien YH; Lu MY; Jou ST; Lin KH; Hwu WL; Lin DT
    J Formos Med Assoc; 2016 Feb; 115(2):94-9. PubMed ID: 26234152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in molecular characterization of myeloid proliferations associated with Down syndrome.
    Li J; Kalev-Zylinska ML
    Front Genet; 2022; 13():891214. PubMed ID: 36035173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematological disturbances in Down syndrome: single centre experience of thirteen years and review of the literature.
    Karakurt N; Uslu İ; Aygün C; Albayrak C
    Turk J Pediatr; 2019; 61(5):664-670. PubMed ID: 32104997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA1 mutations in acute leukemia in children with Down syndrome.
    Magalhães IQ; Splendore A; Emerenciano M; Figueiredo A; Ferrari I; Pombo-de-Oliveira MS
    Cancer Genet Cytogenet; 2006 Apr; 166(2):112-6. PubMed ID: 16631466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal Myeloproliferative Disorders in Patients with Down Syndrome-Treatment and Outcome Results from an Institution in Argentina.
    Pennella CL; Cassina TM; Rossi JG; Baialardo EM; Rubio P; Deu MA; Peruzzo L; Guitter MR; Sanchez de La Rosa CG; Alfaro EM; Felice MS
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient myeloproliferative disorder and GATA1 mutation in neonates with and without Down syndrome.
    Tsai MH; Hou JW; Yang CP; Yang PH; Chu SM; Hsu JF; Chiang MC; Huang HR
    Indian J Pediatr; 2011 Jul; 78(7):826-32. PubMed ID: 21287369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy.
    Qian H; Wang Y; Ma Z; Qian L; Shao X; Jin D; Cao M; Liu S; Chen H; Pan J; Xue W
    Int J Nanomedicine; 2022; 17():1635-1646. PubMed ID: 35411143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.
    Malinge S; Bliss-Moreau M; Kirsammer G; Diebold L; Chlon T; Gurbuxani S; Crispino JD
    J Clin Invest; 2012 Mar; 122(3):948-62. PubMed ID: 22354171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient leukemia of Down syndrome.
    Sas V; Blag C; Zaharie G; Puscas E; Lisencu C; Andronic-Gorcea N; Pasca S; Petrushev B; Chis I; Marian M; Dima D; Teodorescu P; Iluta S; Zdrenghea M; Berindan-Neagoe I; Popa G; Man S; Colita A; Stefan C; Kojima S; Tomuleasa C
    Crit Rev Clin Lab Sci; 2019 Jun; 56(4):247-259. PubMed ID: 31043105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmonic Gold Nanohole Array for Surface-Enhanced Raman Scattering Detection of DNA Methylation.
    Luo X; Xing Y; Galvan DD; Zheng E; Wu P; Cai C; Yu Q
    ACS Sens; 2019 Jun; 4(6):1534-1542. PubMed ID: 31074265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
    Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
    Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-Analysis of DNA Methylation Datasets Shows Aberrant DNA Methylation of Thyroid Development or Function Genes in Down Syndrome.
    Lauffer P; Zwaveling-Soonawala N; Li S; Bacalini MG; Naumova OY; Wiemels J; Boelen A; Henneman P; de Smith AJ; van Trotsenburg ASP
    Thyroid; 2023 Jan; 33(1):53-62. PubMed ID: 36326208
    [No Abstract]   [Full Text] [Related]  

  • 33. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).
    Pelleri MC; Piovesan A; Caracausi M; Berardi AC; Vitale L; Strippoli P
    BMC Med Genomics; 2014 Dec; 7():63. PubMed ID: 25476127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematological disorders in children with Down syndrome.
    Triarico S; Trombatore G; Capozza MA; Romano A; Mastrangelo S; Attinà G; Maurizi P; Ruggiero A
    Expert Rev Hematol; 2022 Feb; 15(2):127-135. PubMed ID: 35184659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
    Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
    Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
    Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis.
    Gadgeel M; AlQanber B; Buck S; Taub JW; Ravindranath Y; Savaşan S
    Ann Hematol; 2021 Jul; 100(7):1695-1700. PubMed ID: 33890142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin.
    Taub JW; Huang X; Matherly LH; Stout ML; Buck SA; Massey GV; Becton DL; Chang MN; Weinstein HJ; Ravindranath Y
    Blood; 1999 Aug; 94(4):1393-400. PubMed ID: 10438727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetic and molecular studies of Down syndrome individuals with leukemia.
    Shen JJ; Williams BJ; Zipursky A; Doyle J; Sherman SL; Jacobs PA; Shugar AL; Soukup SW; Hassold TJ
    Am J Hum Genet; 1995 Apr; 56(4):915-25. PubMed ID: 7717402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.